Andrea Špolcová

Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration

Veronika Nagelová, Anežka Tichá, Jana Zemenová et al. · International Journal of Obesity · 2015 · 67 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +5

Hypooxytocinaemia in obese Zucker rats relates to oxytocin degradation in liver and adipose tissue

Lucia Gajdošechová, Katarína Kršková, Ana Belén Segarra et al. · Journal of Endocrinology · 2014 · 54 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Anorexigenic Lipopeptides Ameliorate Central Insulin Signaling and Attenuate Tau Phosphorylation in Hippocampi of Mice with Monosodium Glutamate-Induced Obesity

Andrea Špolcová, Barbora Mikulášková, Martina Holubová et al. · Journal of Alzheimer s Disease · 2015 · 47 citations

Life Sciences, Neuroscience, Pharmacology +16

The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity

Resha Matyšková, Jana Maixnerová, David Sýkora et al. · Molecular and Cellular Endocrinology · 2011 · 44 citations

Medicine, Endocrinology, Pharmacology +13

Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration

Lenka Maletı́nská, Anežka Tichá, Veronika Nagelová et al. · Brain Research · 2013 · 39 citations

Medicine, Neuroscience, Pharmacology +16